Denmark· DK-28106684221
Zynlonta
A loncastuximab tesirine product containing loncastuximab tesirin, registered in Denmark by Swedish Orphan Biovitrum AB. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Loncastuximab tesirine is registered in 11 of 19 countries.
Countries holding a registration under ATC L01FX22 (loncastuximab tesirine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Loncastuximab tesirine · ATC L01FX22
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Loncastuximab tesirin
- Manufacturer
- Swedish Orphan Biovitrum AB
- Country
- Denmark (DK)
- ATC code
- L01FX22
- ATC class
- Loncastuximab tesirine
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106684221
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01FX22
Loncastuximab tesirine, as other registers publish it.
- FinlandZynlontaSwedish Orphan Biovitrum AB (publ)
- IcelandZynlontaSwedish Orphan Biovitrum AB (publ)
- NorwayZynlontaSwedish Orphan Biovitrum
- PolandZynlontaSwedish Orphan Biovitrum AB (publ)
- United StatesZYNLONTAADC Therapeutics America, Inc.
- CzechiaZYNLONTASwedish Orphan Biovitrum AB (publ), Stockholm
- United StatesZYNLONTAADC Therapeutics America, Inc.
- BelgiumZynlonta 10 mgSwedish Orphan Biovitrum (Publ)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3a4f75c-6545-4bba-8fc7-5e1a7e0ff299 GET /v1/drugs/f3a4f75c-6545-4bba-8fc7-5e1a7e0ff299?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "10 mg",
"auth_role": "RAP",
"dk_drugid": "28106684221",
"substance": "Loncastuximab tesirin",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "44915"
}See everything about loncastuximab tesirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.